Coccidioidomycosis complicating solid organ transplantation

Joy L. Logan, Janis E. Blair, John N. Galgiani

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Coccidioidomycosis is the most common endemic mycosis to cause disease in solid-organ transplant patients in North America. Underlying renal and liver disease, T-lymphocyte suppression from antirejection medication, and activation of immunomodulating viruses, such as cytomegalovirus, all increase the risk for coccidioidomycosis among these patients. About one half of all cases are the result of reactivation of previously acquired coccidioidal infection and occur during the first year after transplantation. Although disseminated infection is common, most cases manifest pulmonary symptoms. Culture of pulmonary secretions from bronchoscopy is frequently diagnostic. Serologic tests are particularly useful for identifying patients who are at high risk for reactivating coccidioidomycosis posttransplantation. Amphotericin B and azoles are the mainstay of therapy. Although there are no established approaches to preventing coccidioidomycosis among these patients, studies are underway examining the use of prophylactic azole antifungals with documented prior coccidioidal infection.

Original languageEnglish (US)
Pages (from-to)251-256
Number of pages6
JournalSeminars in Respiratory Infections
Volume16
Issue number4
DOIs
StatePublished - 2001

Fingerprint

Coccidioidomycosis
Organ Transplantation
Azoles
Infection
Virus Activation
Lung
Mycoses
Bronchoscopy
Serologic Tests
Amphotericin B
North America
Cytomegalovirus
Liver Diseases
Transplantation
T-Lymphocytes
Transplants
Kidney

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Microbiology (medical)

Cite this

Coccidioidomycosis complicating solid organ transplantation. / Logan, Joy L.; Blair, Janis E.; Galgiani, John N.

In: Seminars in Respiratory Infections, Vol. 16, No. 4, 2001, p. 251-256.

Research output: Contribution to journalArticle

Logan, Joy L. ; Blair, Janis E. ; Galgiani, John N. / Coccidioidomycosis complicating solid organ transplantation. In: Seminars in Respiratory Infections. 2001 ; Vol. 16, No. 4. pp. 251-256.
@article{bc18c9d39dbe481bac80a3f85072cd50,
title = "Coccidioidomycosis complicating solid organ transplantation",
abstract = "Coccidioidomycosis is the most common endemic mycosis to cause disease in solid-organ transplant patients in North America. Underlying renal and liver disease, T-lymphocyte suppression from antirejection medication, and activation of immunomodulating viruses, such as cytomegalovirus, all increase the risk for coccidioidomycosis among these patients. About one half of all cases are the result of reactivation of previously acquired coccidioidal infection and occur during the first year after transplantation. Although disseminated infection is common, most cases manifest pulmonary symptoms. Culture of pulmonary secretions from bronchoscopy is frequently diagnostic. Serologic tests are particularly useful for identifying patients who are at high risk for reactivating coccidioidomycosis posttransplantation. Amphotericin B and azoles are the mainstay of therapy. Although there are no established approaches to preventing coccidioidomycosis among these patients, studies are underway examining the use of prophylactic azole antifungals with documented prior coccidioidal infection.",
author = "Logan, {Joy L.} and Blair, {Janis E.} and Galgiani, {John N.}",
year = "2001",
doi = "10.1053/srin.2001.29318",
language = "English (US)",
volume = "16",
pages = "251--256",
journal = "Seminars in Respiratory Infections",
issn = "0882-0546",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - Coccidioidomycosis complicating solid organ transplantation

AU - Logan, Joy L.

AU - Blair, Janis E.

AU - Galgiani, John N.

PY - 2001

Y1 - 2001

N2 - Coccidioidomycosis is the most common endemic mycosis to cause disease in solid-organ transplant patients in North America. Underlying renal and liver disease, T-lymphocyte suppression from antirejection medication, and activation of immunomodulating viruses, such as cytomegalovirus, all increase the risk for coccidioidomycosis among these patients. About one half of all cases are the result of reactivation of previously acquired coccidioidal infection and occur during the first year after transplantation. Although disseminated infection is common, most cases manifest pulmonary symptoms. Culture of pulmonary secretions from bronchoscopy is frequently diagnostic. Serologic tests are particularly useful for identifying patients who are at high risk for reactivating coccidioidomycosis posttransplantation. Amphotericin B and azoles are the mainstay of therapy. Although there are no established approaches to preventing coccidioidomycosis among these patients, studies are underway examining the use of prophylactic azole antifungals with documented prior coccidioidal infection.

AB - Coccidioidomycosis is the most common endemic mycosis to cause disease in solid-organ transplant patients in North America. Underlying renal and liver disease, T-lymphocyte suppression from antirejection medication, and activation of immunomodulating viruses, such as cytomegalovirus, all increase the risk for coccidioidomycosis among these patients. About one half of all cases are the result of reactivation of previously acquired coccidioidal infection and occur during the first year after transplantation. Although disseminated infection is common, most cases manifest pulmonary symptoms. Culture of pulmonary secretions from bronchoscopy is frequently diagnostic. Serologic tests are particularly useful for identifying patients who are at high risk for reactivating coccidioidomycosis posttransplantation. Amphotericin B and azoles are the mainstay of therapy. Although there are no established approaches to preventing coccidioidomycosis among these patients, studies are underway examining the use of prophylactic azole antifungals with documented prior coccidioidal infection.

UR - http://www.scopus.com/inward/record.url?scp=0035668221&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035668221&partnerID=8YFLogxK

U2 - 10.1053/srin.2001.29318

DO - 10.1053/srin.2001.29318

M3 - Article

C2 - 11740826

AN - SCOPUS:0035668221

VL - 16

SP - 251

EP - 256

JO - Seminars in Respiratory Infections

JF - Seminars in Respiratory Infections

SN - 0882-0546

IS - 4

ER -